CYP21A2 polymorphisms in patients with autoimmune Addison's disease, and linkage disequilibrium to HLA risk alleles

European Journal of Endocrinology

Volumn 171, Issue 6, 2014, Pages 743-750

  Bronstad, Ingeborg ^a   Skinningsrud, Beate ^b   Bratland, Eirik ^a   Lovas, Kristian ^a,c   Undlien, Dag ^b,d   Husebye, Eystein Sverre ^a,c   Wolff, Anette Susanne Boe ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HLA A ANTIGEN; HLA B ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; STEROID 21 MONOOXYGENASE; CYP21A2 PROTEIN, HUMAN;

ADDISON DISEASE; ARTICLE; CHROMOSOME 6P; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; CYP21A2 GENE; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HIGH RISK PATIENT; HLA A GENE; HLA B GENE; HLA DQB1 GENE; HLA DRB1 GENE; HLA GENE; HUMAN; MAJOR CLINICAL STUDY; MICA GENE; MUTATIONAL ANALYSIS; NORWAY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; CASE CONTROL STUDY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; MALE; MIDDLE AGED;

ADDISON DISEASE; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HLA-DRB1 CHAINS; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; STEROID 21-HYDROXYLASE;

EID: 84911958842     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-14-0432     Document Type: Article

References (40)

1. Arlt W & Allolio B. Adrenal insufficiency. Lancet 2003 361 1881-1893. (doi:10.1016/S0140-6736(03)13492-7)
2. Erichsen MM, Lovas K, Skinningsrud B, Wolff AB, Undlien DE, Svartberg J, Fougner KJ, Berg TJ, Bollerslev J, Mella B et al. Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. Journal of Clinical Endocrinology and Metabolism 2009 94 4882-4890. (doi:10.1210/jc.2009-1368)
3. Husebye ES, Perheentupa J, Rautemaa R & Kampe O. Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I. Journal of Internal Medicine 2009 265 514-529. (doi:10.1111/j.1365-2796.2009.02090.x)
4. Skinningsrud B, Lie BA, Lavant E, Carlson JA, Erlich H, Akselsen HE, Gervin K, Wolff AB, Erichsen MM, Lovas K et al. Multiple loci in the HLA complex are associated with Addison's disease. Journal of Clinical Endocrinology and Metabolism 2011 96 E1703-E1708. (doi:10.1210/jc.2011-0645)
5. Gambelunghe G, Falorni A, Ghaderi M, Laureti S, Tortoioli C, Santeusanio F, Brunetti P & Sanjeevi CB. Microsatellite polymorphism of the MHC class I chain-related (MIC-A and MIC-B) genes marks the risk for autoimmune Addison's disease. Journal of Clinical Endocrinology and Metabolism 1999 84 3701-3707. (doi:10.1210/jcem.84.10.6069)
6. Park YS, Sanjeevi CB, Robles D, Yu L, Rewers M, Gottlieb PA, Fain P & Eisenbarth GS. Additional association of intra-MHC genes, MICA and D6S273, with Addison's disease. Tissue Antigens 2002 60 155-163. (doi:10.1034/j.1399-0039.2002.600206.x)
7. Triolo TM, Baschal EE, Armstrong TK, Toews CS, Fain PR, Rewers MJ, Yu L, Miao D, Eisenbarth GS, Gottlieb PA et al. Homozygosity of the polymorphism MICA5.1 identifies extreme risk of progression to overt adrenal insufficiency among 21-hydroxylase antibody-positive patients with type 1 diabetes. Journal of Clinical Endocrinology and Metabolism 2009 94 4517-4523. (doi:10.1210/jc.2009-1308)
8. Blomhoff A, Lie BA, Myhre AG, Kemp EH, Weetman AP, Akselsen HE, Huseby ES & Undlien DE. Polymorphisms in the cytotoxic T lymphocyte antigen-4 gene region confer susceptibility to Addison's disease. Journal of Clinical Endocrinology and Metabolism 2004 89 3474-3476. (doi:10.1210/jc.2003-031854)
9. Brozzetti A, Marzotti S, Tortoioli C, Bini V, Giordano R, Dotta F, Betterle C, De Bellis A, Arnaldi G, Toscano V et al. Italian Addison N. Cytotoxic T lymphocyte antigen-4 Ala17 polymorphism is a genetic marker of autoimmune adrenal insufficiency: Italian association study and meta-analysis of European studies. European Journal of Endocrinology 2010 162 361-369. (doi:10.1530/EJE-09-0618)
10. Roycroft M, Fichna M, McDonald D, Owen K, Zurawek M, Gryczynska M, Januszkiewicz-Lewandowska D, Fichna P, Cordell H, Donaldson P et al. The tryptophan 620 allele of the lymphoid tyrosine phosphatase (PTPN22) gene predisposes to autoimmune Addison's disease. Clinical Endocrinology 2009 70 358-362. (doi:10.1111/j.1365-2265.2008.03380.x)
11. Skinningsrud B, Husebye ES, Gervin K, Lovas K, Blomhoff A, Wolff AB, Kemp EH, Egeland T & Undlien DE. Mutation screening of PTPN22: association of the 1858T-allele with Addison's disease. European Journal of Human Genetics 2008 16 977-982. (doi:10.1038/ejhg.2008.33)
12. Skinningsrud B, Husebye ES, Pearce SH, McDonald DO, Brandal K, Wolff AB, Lovas K, Egeland T & Undlien DE. Polymorphisms in CLEC16A and CIITA at 16p13 are associated with primary adrenal insufficiency. Journal of Clinical Endocrinology and Metabolism 2008 93 3310-3317. (doi:10.1210/jc.2008-0821)
13. Jennings CE, Owen CJ, Wilson V & Pearce SH. A haplotype of the CYP27B1 promoter is associated with autoimmune Addison's disease but not with Graves' disease in a UK population. Journal of Molecular Endocrinology 2005 34 859-863. (doi:10.1677/jme.1.01760)
14. Lopez ER, Zwermann O, Segni M, Meyer G, Reincke M, Seissler J, Herwig J, Usadel KH & Badenhoop K. A promoter polymorphism of the CYP27B1 gene is associated with Addison's disease, Hashimoto's thyroiditis, Graves' disease and type 1 diabetes mellitus in Germans. European Journal of Endocrinology 2004 151 193-197. (doi:10.1530/eje.0.1510193)
15. Mitchell AL, Cordell HJ, Soemedi R, Owen K, Skinningsrud B, Wolff AB, Ericksen M, Undlien D, Husebye E & Pearce SH. Programmed death ligand 1 (PD-L1) gene variants contribute to autoimmune Addison's disease and Graves' disease susceptibility. Journal of Clinical Endocrinology and Metabolism 2009 94 5139-5145. (doi:10.1210/jc.2009-1404)
16. Winqvist O, Karlsson FA & Kampe O. 21-hydroxylase, a major autoantigen in idiopathic Addison's disease. Lancet 1992 339 1559-1562. (doi:10.1016/0140-6736(92)91829-W)
17. Betterle C, Scarpa R, Garelli S, Morlin L, Lazzarotto F, Presotto F, Coco G, Masiero S, Parolo A, Albergoni MP et al. Addison's disease: a survey on 633 patients in Padova. European Journal of Endocrinology 2013 169 773-784. (doi:10.1530/EJE-13-0528)
18. Falorni A, Laureti S, Nikoshkov A, Picchio ML, Hallengren B, Vandewalle CL, Gorus FK, Tortoioli C, Luthman H, Brunetti P et al. 21-hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison's disease. Belgian Diabetes Registry. Clinical and Experimental Immunology 1997 107 341-346. (doi:10.1111/j.1365-2249.1997.262-ce1153.x)
19. Seissler J, Schott M, Steinbrenner H, Peterson P & Scherbaum WA. Autoantibodies to adrenal cytochrome P450 antigens in isolated Addison's disease and autoimmune polyendocrine syndrome type II. Experimental and Clinical Endocrinology & Diabetes 1999 107 208-213. (doi:10.1055/s-0029-1212100)
20. Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, Meyer-Bahlburg HF, Miller WL, Montori VM, Oberfield SE et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2010 95 4133-4160. (doi:10.1210/jc.2009-2631)
21. White PC, New MI & Dupont B. Structure of human steroid 21-hydroxylase genes. PNAS 1986 83 5111-5115. (doi:10.1073/pnas.83.14.5111)
22. Wenzlau JM, Liu Y, Yu L, Moua O, Fowler KT, Rangasamy S, Walters J, Eisenbarth GS, Davidson HW & Hutton JC. A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes. Diabetes 2008 57 2693-2697. (doi:10.2337/db08-0522)
23. Dechairo BM, Zabaneh D, Collins J, Brand O, Dawson GJ, Green AP, Mackay I, Franklyn JA, Connell JM,Wass JA et al. Association of the TSHR genewithGraves' disease: the first disease specific locus. European Journal of Human Genetics 2005 13 1223-1230. (doi:10.1038/sj.ejhg.5201485)
24. Brand OJ, Barrett JC, Simmonds MJ, Newby PR, McCabe CJ, Bruce CK, Kysela B, Carr-Smith JD, Brix T, Hunt PJ et al. Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves' disease. Human Molecular Genetics 2009 18 1704-1713. (doi:10.1093/hmg/ddp087)
25. Nikoshkov A, Falorni A, Lajic S, Laureti S, Wedell A, Lernmark K & Luthman H. A conformation-dependent epitope in Addison's disease and other endocrinological autoimmune diseases maps to a carboxylterminal functional domain of human steroid 21-hydroxylase. Journal of Immunology 1999 162 2422-2426.
26. Peterson P, Partanen J, Aavik E, Salmi H, Pelkonen R & Krohn KJ. Steroid 21-hydroxylase gene polymorphism in Addison's disease patients. Tissue Antigens 1995 46 63-67. (doi:10.1111/j.1399-0039.1995.tb02478.x)
27. Wedell A & Luthman H. Steroid 21-hydroxylase deficiency: two additional mutations in salt-wasting disease and rapid screening of disease-causing mutations. Human Molecular Genetics 1993 2 499-504. (doi:10.1093/hmg/2.5.499)
28. Wilson RC, Wei JQ, Cheng KC, Mercado AB & New MI. Rapid deoxyribonucleic acid analysis by allele-specific polymerase chain reaction for detection of mutations in the steroid 21-hydroxylase gene. Journal of Clinical Endocrinology and Metabolism 1995 80 1635-1640. (doi:10.1210/jcem.80.5.7745011)
29. Lau IF, Soardi FC, Lemos-Marini SH, Guerra B Jr, Baptista MT & De Mello MP. H28+C insertion in the CYP21 gene: a novel frameshift mutation in a Brazilian patient with the classical form of 21-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism 2001 86 5877-5880. (doi:10.1210/jcem.86.12.8113)
30. Parajes S, Quinterio C, Dominguez F & Loidi L. A simple and robust quantitative PCR assay to determine CYP21A2 gene dose in the diagnosis of 21-hydroxylase deficiency. Clinical Chemistry 2007 53 1577-1584. (doi:10.1373/clinchem.2007.087361)
31. Barrett JC, Fry B, Maller J & Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005 21 263-265. (doi:10.1093/bioinformatics/bth457)
32. Dudbridge F. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Human Heredity 2008 66 87-98. (doi:10.1159/000119108)
33. Stephens M, Smith NJ & Donnelly P. A new statistical method for haplotype reconstruction from population data. American Journal of Human Genetics 2001 68 978-989. (doi:10.1086/319501)
34. Wedell A. Congenital adrenal hyperplasia. Clinical Biochemistry 2011 44 505-506. (doi:10.1016/j.clinbiochem.2011.02.026)
35. Baker PR, Baschal EE, Fain PR, Triolo TM, Nanduri P, Siebert JC, Armstrong TK, Babu SR, Rewers MJ, Gottlieb PA et al. Haplotype analysis discriminates genetic risk for DR3-associated endocrine autoimmunity and helps define extreme risk for Addison's disease. Journal of Clinical Endocrinology and Metabolism 2010 95 E263-E270. (doi:10.1210/jc.2010-0508)
36. Yu L, Brewer GS, Gates S, Wu A, Wang T, Babu SR, Gottlieb PA, Freed BM, Noble J, Erlich HA et al. DRB1∗04 and DQ alleles: expression of 21-hydroxylase autoantibodies and risk of progression to Addison's disease. Journal of Clinical Endocrinology and Metabolism 1999 84 328-335. (doi:10.1210/jcem.84.1.5414)
37. Blasko B, Banlaki Z, Gyapay G, Pozsonyi E, Sasvari-Szekely M, Rajczy K, Fust G & Szilagyi A. Linkage analysis of the C4A/C4B copy number variation and polymorphisms of the adjacent steroid 21-hydroxylase gene in a healthy population. Molecular Immunology 2009 46 2623-2629. (doi:10.1016/j.molimm.2009.04.033)
38. Barker JM, Ide A, Hostetler C, Yu L, Miao D, Fain PR, Eisenbarth GS & Gottlieb PA. Endocrine and immunogenetic testing in individuals with type 1 diabetes and 21-hydroxylase autoantibodies: Addison's disease in a high-risk population. Journal of Clinical Endocrinology and Metabolism 2005 90 128-134. (doi:10.1210/jc.2004-0874)
39. Durinovic-Bello I, Wu RP, Gersuk VH, Sanda S, Shilling HG & Nepom GT. Insulin gene VNTR genotype associates with frequency and phenotype of the autoimmune response to proinsulin. Genes and Immunity 2010 11 188-193. (doi:10.1038/gene.2009.108)
40. Pugliese A, Zeller M, Fernandez A Jr, Zalcberg LJ, Bartlett RJ, Ricordi C, Pietropaolo M, Eisenbarth GS, Bennett ST & Patel DD. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nature Genetics 1997 15 293-297. (doi:10.1038/ng0397-293)